Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Curr Psychiatry Rep ; 21(4): 23, 2019 03 09.
Artigo em Inglês | MEDLINE | ID: mdl-30852710

RESUMO

PURPOSE OF REVIEW: Phenibut (ß-phenyl-γ-aminobutyric acid) is a psychoactive GABA analogue currently being marketed online as an anxiolytic and nootropic dietary supplement. Its use is growing in popularity, but its pharmacological activity is well beyond that of a conventional nutritional supplement, and similar to that of a prescription strength sedative. This review will focus on the potential adversities of phenibut use and will discuss what treatment options may be beneficial to afflicted patients. RECENT FINDINGS: Over the last several years, multiple case reports have highlighted phenibut's potential to produce the conditions of physical dependence, withdrawal, and addiction. In cases involving intoxication, patients have presented with a varying degree of mental status changes, from being minimally responsive to manifesting symptoms of an agitated delirium. Phenibut is a potent psychoactive substance with GABAB agonist properties, which is emerging as a drug of misuse through growing internet sales. Its marketing as a "dietary supplement" is inaccurate and misleading, given its pharmacological profile and ability to induce the physiological changes associated with withdrawal and physical dependence.


Assuntos
Suplementos Nutricionais/efeitos adversos , Transtornos Relacionados ao Uso de Substâncias/etiologia , Ácido gama-Aminobutírico/análogos & derivados , Comportamento Aditivo/etiologia , Humanos , Hipnóticos e Sedativos/efeitos adversos , Nootrópicos/efeitos adversos , Ácido gama-Aminobutírico/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...